英文名称 | 中文名称 | CAS |
---|---|---|
Canertinib | 卡奈替尼 | 267243-28-7 |
Motesanib | 莫特塞尼 | 453562-69-1 |
JNJ38877605 | 6-[二氟[6-(1-甲基-1H-吡唑-4-基)-1,2,4-噻唑并[4,3-B]吡嗪-3-基]甲基]-喹啉 | 943540-75-8 |
BEZ235 | NVP-BEZ235 | 915019-65-7 |
CYC-116 | CYC-116 | 693228-63-6 |
Bayer-18 | N-叔丁基-N'-[3-[[5-氟-4-[(2-羟基-1,1-二甲基乙基)氨基]-2-嘧啶基]氨基]苯基]脲 | 1251752-12-1 |
CH5132799 | CH5132799 | 1007207-67-1 |
isoxazolo[5,4-b]pyridin-3-aMine | 异恶唑并[5,4-B]吡啶-3-胺 | 92914-74-4 |
Purvalanol B | (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇 | 212844-54-7 |
Dovitinib | 4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮 | 405169-16-6 |
DianilinopyriMidine_01 | N2-(4-(氨甲基)苯)-5-氟-N4-苯基嘧啶-2,4-二胺 | 916603-07-1 |
LY294002 | LY294002/PI3K抑制剂 | 154447-36-6 |
BI-D1870 | BI-D1870 | 501437-28-1 |
BMS-599626 | AC480 (BMS-599626) | 714971-09-2 |
Crizotinib | 克唑替尼 | 877399-52-5 |
PIK-90 | N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 | 677338-12-4 |
E7080 | 乐伐替尼 | 417716-92-8 |
IC87114 | 2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | 371242-69-2 |
Brivanib alaninate | 1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2-丙醇 L-丙氨酸酯 | 649735-63-7 |
Ponatinib | 帕纳替尼 | 943319-70-8 |
PIK-294 | PIK-294 | 900185-02-6 |
diethyl 7-oxo-4,7-dihydropyrazolo[1,5-a]pyriMidine-3,6-dicarboxylate | 7-氧代-4,7-二氢吡唑并[1,5-A]-嘧啶-3,6-二羧酸二乙酯 | 155374-25-7 |
BMS-5 | ||
CI-1040 | 2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 | 212631-79-3 |
GW441756 | GW441756 | 504433-23-2 |
Mubritinib | 木利替尼 | 366017-09-6 |
MK-2461 | MK-2461 | 917879-39-1 |
ethyl 7-oxo-4,7-dihydropyrazolo[1,5-a]pyriMidine-3-carboxylate | 7-氧代-4,7-二氢吡唑并[1,5-A]嘧啶-3-羧酸乙酯 | 104556-86-7 |
ethyl 5-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate | 5-氯吡唑并[1,5-a]嘧啶-3-羧酸乙酯 | 1224944-77-7 |
PIK-93 | N-[5-[4-氯-3-[[(2-羟基乙基)氨基]磺酰基]苯基]-4-甲基-2-噻唑基]乙酰胺 | 593960-11-3 |
PHA690509 | (2S)-2-[4-(乙酰基氨基)苯基]-N-(5-异丙基噻唑-2-基)丙酰胺 | 492445-28-0 |
MoMelotinib | 莫洛替尼 | 1056634-68-4 |
GNE-493 | GNE-493 | 1033735-94-2 |
Merck-22-6 | Merck-22-6 | 12847-42-4 |
Erlotinib Hydrochloride | 盐酸埃罗替尼 | 183319-69-9 |
Neratinib | 来那替尼 | 698387-09-6 |
BI-2536 | BI 2536 | 755038-02-9 |
ethyl 7-aMinopyrazolo[1,5-a]pyriMidine-3-carboxylate | 7-氨基吡唑并[1,5-A]嘧啶-3-羧酸乙酯 | 1196153-97-5 |
GDC0980 | (S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羟基丙-1-酮 | 1032754-93-0 |
BMS-3 | ||
ethyl 2-(Methylthio)-4-oxo-3,4-dihydropyrazolo[1,5-a][1,3,5]triazine-8-carboxylate | 278600-53-6 | |
Merck-5 | 2-(1,1-二甲基乙基)-9-氟-1,6-二氢-7H-苯并[H]咪唑并[4,5-F]异喹啉-7-酮 | 457081-03-7 |
Masatinib | 马赛替尼(Masitinib) | 790299-79-5 |
GDC-0941 | GDC-0941 | 957054-30-7 |
PD0325901 | N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺 | 391210-10-9 |
KU0063794 | KU-0063794 | 938440-64-3 |
ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyriMidine-3-carboxylate | 5-氧代-4,5-二氢吡唑并[1,5-a]嘧啶-3-羧酸乙酯 | 926663-00-5 |
Ki20227 | Ki20227 | 623142-96-1 |
PF431396 | N-甲基-N-[2-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]苯基]甲磺酰胺 | 717906-29-1 |
BX-795 | N-[3-[[5-碘-4-[[3-[(2-噻吩基羰基)氨基]丙基]氨基]-2-嘧啶基]氨基]苯基]-1-吡咯烷甲酰胺 | 702675-74-9 |
Pazopanib HCl | 盐酸帕唑帕尼 | 635702-64-6 |
BS194 | (2S,3S)-3-[[3-(异丙基)-7-[(苯基甲基)氨基]吡唑并[1,5-A]嘧啶-5-基]氨基]-1,2,4-丁三醇 | 1092443-55-4 |
ethyl 3-aMinothieno[2,3-b]pyridine-2-carboxylate | 3-氨基噻吩并[2,3-B]吡啶-2-甲酸乙酯 | 52505-46-1 |
ethyl pyrazolo[1,5-a]pyriMidine-3-carboxylate | 吡唑并[1,5-A]嘧啶-3-羧酸乙酯 | 115932-00-8 |
Dasatinib | 达沙替尼 | 302962-49-8 |
ethyl 3-cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyriMidine-6-carboxylate | 3-氰基-7-氧代-4,7-二氢吡唑并[1,5-A]嘧啶-6-羧酸乙酯 | 64689-83-4 |
ethyl 3-aMinofuro[2,3-b]pyridine-2-carboxylate | 3-氨基-呋喃并[2,3-B]嘧啶-2-甲酸乙酯 | 371945-06-1 |
Linifanib | 利尼伐尼 | 796967-16-3 |
ethyl 7-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate | 乙基 7-氯吡唑并[1,5-A]嘧啶-3-甲酸基酯 | 749216-54-4 |
ethyl 7-aMino-5-hydroxypyrazolo[1,5-a]pyriMidine-3-carboxylate | 7-氨基-5-氧代-4,5-二氢吡唑并[1,5-A]嘧啶-3-羧酸乙酯 | 90674-09-2 |
PIK-75 | 2-甲基-5-硝基-1-苯磺酰[2-[(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]-1-甲基肼] | 372196-67-3 |
PF04217903 | 2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 | 956905-27-4 |
NVP-BGJ398 | FGFR抑制剂(NVP-BGJ398) | 872511-34-7 |
BisindolylMaleiMide X, HCl salt | RO 31-8425 | 1241725-87-0 |
GPLG0634 | 非戈替尼 | 1206161-97-8 |
NIBR-17 | CS-2663 | 944396-88-7 |
Nilotinib | 尼罗替尼 | 641571-10-0 |
CX-4945 | CX-4945 | 1009820-21-6 |
JNJ7706621 | JNJ-7706621 | 443797-96-4 |
NVP-BSK805 | NVP-BSK805 dihydrochloride | 1092499-93-8 |
GNE 477 | GNE 477 | 1032754-81-6 |
JNJ-28312141 | 4-CYANO-N-[2-(CYCLOHEX-1-EN-1-YL)-4-{1-[2-(DIMETHYLAMINO)ACETYL]PIPERIDIN-4-YL}PHENYL]-1H-IMIDAZOLE-2-CARBOXAMIDE | 885692-52-4 |
IMatinib Mesylate | 甲磺酸伊马替尼 | 221027-57-1 |
PF-562271 | N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 | 717907-75-0 |
PLX4720 | N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 | 918505-84-7 |
Intedanib | 尼达尼布 | 656247-17-5 |
Cabozantinib | 卡博替尼 | 849217-68-1 |
CEP-33779 | N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 | 1346168-57-7 |
Pelitinib | 培利替尼 | 257933-82-7 |
Gefitinib | 吉非替尼 | 184475-35-2 |
Danusertib | 达鲁舍替 | 827318-97-8 |
PI-103 | PI-103 | 371935-74-9 |
BMS-2 | 1-(4-氟苯基)-N-[3-氟-4-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯基]-1,2-二氢-2-氧代-3-吡啶甲酰胺 | 888719-03-7 |
CC-401 | 3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑 | 395104-30-0 |
PD173955 | 6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 | 260415-63-2 |
PD173955-Analog 1 | 3-[[6-(2,6-二氯苯基)-7,8-二氢-8-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基]氨基]苯甲酸 | 185039-99-0 |
GSK-25 | GSK-25 | 874119-56-9 |
KU55933 | 2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 | 587871-26-9 |
Lapatinib | 拉帕替尼 | 231277-92-2 |
Pazopanib | 帕唑帕尼 | 444731-52-6 |
pyrazolo[1,5-a][1,3,5]triazine-2,4-diol | 吡唑并[1,5-A]-1,3,5-三嗪-2,4(1H,3H)-二酮 | 34683-40-4 |
BX-912 | BX-912 | 702674-56-4 |
Brivanib | 酪氨酸激酶抑制剂 | 649735-46-6 |
GSK690693 | 4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 | 937174-76-0 |
CP-724714 | 2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺 | 383432-38-0 |
KU57788 | 8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 | 503468-95-9 |
GSK2126458 | GSK2126458 | 1086062-66-9 |
INK128 | 3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 | 1224844-38-5 |
GNE-490 | 2-(2-氨基-4-甲基-5-嘧啶基)-ALPHA,ALPHA-二甲基-4-(4-吗啉基)噻吩并[3,2-D]嘧啶-6-甲醇 | 1033739-92-2 |
JNJ-38158471 | CS-2660 | 951151-97-6 |
联系方式